Prescription drug · ANDA
Hydroxyzine pamoate NDC 66267-556
Hydroxyzine pamoate 50 mg/1 · Capsule · Oral · NuCare Pharmaceuticals,Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 66267-556-90 | 66267055690 | 90 CAPSULE in 1 BOTTLE (66267-556-90)Marketed from Feb 12, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Hydroxyzine pamoate
- Generic name (nonproprietary)
- hydroxyzine pamoate
- Active ingredients
- Hydroxyzine pamoate — 50 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- NuCare Pharmaceuticals,Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 086183
- Marketing start
- Listing expires
- Other FDA classes
- Histamine Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 66267-556_1136a031-633b-bf6f-e063-6294a90a8828SPL ID 1136a031-633b-bf6f-e063-6294a90a8828SPL set ID 1136a291-2f2f-c025-e063-6294a90a76d7RxCUI 995278UNII M20215MUFRUPC 0366267556903
- Pharmacologic class
- Antihistamine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N466267055690followed by a unit qualifier and the quantityPackage 66267-0556-90. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus. As a sedative when used as premedication and following general anesthesia, hydroxyzine may potentiate meperidine (Demerol ® ) and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 086183
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Hydroxyzine pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-2076 |
| Hydroxyzine pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-5933 |
| Hydroxyzine pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | Unit Dose Solutions, Inc. | 87441-041 |
| Hydroxyzine pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | Unit Dose Solutions, Inc. | 87441-042 |
| Hydroxyzine pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | REMEDYREPACK INC. | 70518-3232 |
| Hydroxyzine pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | Sandoz Inc | 0185-0676 |
| Hydroxyzine Pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | Direct_Rx | 72189-480 |
| Hydroxyzine pamoate | Hydroxyzine pamoate 50 mg/1 | CapsuleOral | Coupler LLC | 67046-0831 |